Afkarian M, Sachs MC, Kestenbaum B, et al
Newer medicines, such as tirzepatide (Mounjaro), also act on a second hormone, offering additional benefits for weight and metabolic control
Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens
Botanical compounds in the glucose-management supplement category can have additive effects with prescription glucose-lowering medications
In addition to its benefits as an anti-hyperglycemic agent, metformin also lowers the atherosclerotic burden in non-diabetic persons at risk of developing T2DM (1, 7)
Add to cart Sale